Shopping Cart 0
Cart Subtotal
AED 0

Biotechnology Media, Sera and Reagents Market by Type (Media, Sera and Reagent), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, and Others), and End User (Biotechnology & Pharmaceutical Companies, Academic Institute, Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 19708

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 33012

Details

According to a new report published by Allied Market Research, titled,"Biotechnology Media, Sera and Reagent Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025,"The global biotechnology media, sera and reagents market was valued at USD 18,794 million in 2017 and is projected to reach USD 32,974 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025. North America was the highest revenue contributor in 2017 and would remain the same throughout the forecast period.

Biotechnology is the branch of science that deals with the study of living organisms and their use to make technological innovations. Media is a nutrient growth substance provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment such as lysogeny broth, serum free media, classical media, chemically defined media among others. In addition, sera are used as additional growth supplement factors owing to the presence of hormones necessary for cell growth, proliferation, and differentiation of cells. Further, reagent is a substance that is used to cause a chemical reaction. Reagents are often used to indicate the presence of another substance.

Based on biotechnology media, sera and reagents market trends by type, the reagent segment accounted for the majority of market share of the global market in 2017. This is attributed to the fact that reagents find their wide applications in all most biotechnological research such as cell culture, biopharmaceutical research and others.

Based on end user, the biotechnology and pharmaceutical company generated the maximum revenue of in 2017. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research.

Key Findings of the Biotechnology Media, Seraand Reagent Market:

Based on end user, research laboratories accounted for nearly one-third share of the biotechnology media, sera and reagents industry in 2017.

The biopharmaceuticals application segment is anticipated to grow with the highest CAGR throughout the forecast period.

Based on region, North America accounted for nearly two-fifth of the global biotechnology media, sera and reagents market share in 2017.

Asia-Pacific is anticipated to grow at the highest rate in the biotechnology media, sera and reagents market during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers, surge in R&D expenditure for the development of biotechnology media, seraand reagent, and growth in prevalence of food allergies. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase awareness & availability about different reagents & media in the market, increase in biotech R&D, and growth in presence of key market players in this region.

The report provides an extensive competitive analysis and profiles of the key market players, such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) are Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.

READ MORE

Table Of Content

Scope

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Market share analysis, 2017

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in R&D Investment

3.4.1.2. Increase in advancements associated with cell culture media

3.4.1.3. High demand for media, sera and reagents

3.4.2. Restraints

3.4.2.1. Dearth of skilled professionals

3.4.2.2. Ethical & scientific concerns associated with culture media

3.4.3. Opportunity

3.4.3.1. Untapped potential of the emerging economies

CHAPTER 4: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Media

4.2.1. Key market trends and opportunity

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.2.4. Lysogeny broth

4.2.4.1. Market size and forecast

4.2.5. Chemically defined media

4.2.5.1. Market size and forecast

4.2.6. Classical media

4.2.6.1. Market size and forecast

4.2.7. Serum-free Media

4.2.7.1. Market size and forecast

4.2.8. Specialty media

4.2.8.1. Market size and forecast

4.2.9. Stem cell media

4.2.9.1. Market size and forecast

4.2.10. Other media

4.2.10.1. Market size and forecast

4.3. Sera

4.3.1. Key market trends and opportunity

4.3.1.1. Market size and forecast

4.3.3. Market analysis, by country

4.3.4. Fetal Bovine Sera Market

4.3.4.1. Market size and forecast

4.3.5. New Born Calf Sera

4.3.5.1. Market size and forecast

4.3.6. others

4.3.6.1. Market size and forecast

4.4. Reagent

4.4.1. Key market trends and opportunity

4.4.1.1. Market size and forecast

4.4.2. Market analysis, by country

4.4.3. Antibiotics

4.4.3.1. Market size and forecast

4.4.4. DNA/RNA Isolation Reagents

4.4.4.1. Market size and forecast

4.4.5. PCR Reagents

4.4.5.1. Market size and forecast

4.4.6. Buffers

4.4.6.1. Market size and forecast

4.4.7. Other reagents

4.4.7.1. Market size and forecast

CHAPTER 5: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cancer research

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Biopharmaceuticals

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Regenerative medicine & tissue engineering

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

5.5. Other Applications

5.5.1. Market size and forecast, by region

5.5.2. Market analysis, by country

CHAPTER 6: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Biotechnology & pharmaceutical industry

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Academic institute

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Research laboratory

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities

7.2.2. North America biotechnology media, sera and reagents market size and forecast, by country

7.2.2.1. U.S. market size and forecast, by type

7.2.2.2. U.S. market size and forecast, by application

7.2.2.3. U.S. biotechnology media, sera and reagents market, by end user

7.2.2.4. Canada market size and forecast, by type

7.2.2.5. Canada biotechnology media, sera and reagents market, by application

7.2.2.6. Canada biotechnology media, sera and reagents market, by end user

7.2.2.7. Mexico biotechnology media, sera and reagents market, by type

7.2.2.8. Mexico biotechnology media, sera and reagents market, by application

7.2.2.9. Mexico biotechnology media, sera and reagents market, by end user

7.2.3. North America biotechnology media, sera and reagents market size and forecast, by type

7.2.4. North America biotechnology media, sera and reagents market size and forecast, by application

7.2.5. North America biotechnology media, sera and reagents market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends

7.3.2. Europe biotechnology media, sera and reagents market size and forecast, by country

7.3.2.1. Germany market size and forecast, by type

7.3.2.2. Germany biotechnology media, sera and reagents market, by application

7.3.2.3. Germany biotechnology media, sera and reagents market, by end user

7.3.2.4. France market size and forecast, by type

7.3.2.5. France biotechnology media, sera and reagents market, by application

7.3.2.6. France biotechnology media, sera and reagents market, by end user

7.3.2.7. UK market size and forecast, by type

7.3.2.8. UK biotechnology media, sera and reagents market, by application

7.3.2.9. UK biotechnology media, sera and reagents market, by end user

7.3.2.10. Italy market size and forecast, by type

7.3.2.11. Italy biotechnology media, sera and reagents market, by application

7.3.2.12. Italy biotechnology media, sera and reagents market, by end user

7.3.2.13. Spain biotechnology media, sera and reagents market, by type

7.3.2.14. Spain biotechnology media, sera and reagents market, by application

7.3.2.15. Spain biotechnology media, sera and reagents market, by end user

7.3.2.16. Rest of Europe biotechnology media, sera and reagents market, by type

7.3.2.17. Rest of Europe biotechnology media, sera and reagents market, by application

7.3.2.18. Rest of Europe biotechnology media, sera and reagents market, by end user

7.3.3. Europe biotechnology media, sera and reagents market size and forecast, by type

7.3.4. Europe biotechnology media, sera and reagents market size and forecast, by application

7.3.5. Europe biotechnology media, sera and reagents market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends

7.4.2. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by country

7.4.2.1. Japan biotechnology media, sera and reagents market, by type

7.4.2.2. Japan biotechnology media, sera and reagents market, by application

7.4.2.3. Japan biotechnology media, sera and reagents market, by end user

7.4.2.4. China biotechnology media, sera and reagents market, by type

7.4.2.5. China biotechnology media, sera and reagents market, by application

7.4.2.6. China biotechnology media, sera and reagents market, by end user

7.4.2.7. India biotechnology media, sera and reagents market, by type

7.4.2.8. India biotechnology media, sera and reagents market, by application

7.4.2.9. India biotechnology media, sera and reagents market, by end user

7.4.2.10. Australia biotechnology media, sera and reagents market, by type

7.4.2.11. Australia biotechnology media, sera and reagents market, by application

7.4.2.12. Australia biotechnology media, sera and reagents market, by end user

7.4.2.13. South Korea biotechnology media, sera and reagents market, by type

7.4.2.14. South Korea biotechnology media, sera and reagents market, by application

7.4.2.15. South Korea biotechnology media, sera and reagents market, by end user

7.4.2.16. Taiwan biotechnology media, sera and reagents market, by type

7.4.2.17. Taiwan biotechnology media, sera and reagents market, by application

7.4.2.18. Taiwan biotechnology media, sera and reagents market, by end user

7.4.2.19. Rest of Asia-Pacific biotechnology media, sera and reagents market, by type

7.4.2.20. Rest of Asia-Pacific biotechnology media, sera and reagents market, by application

7.4.2.21. Rest of Asia-Pacific biotechnology media, sera and reagents market, by end user

7.4.3. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by type

7.4.4. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by application

7.4.5. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends

7.5.2. LAMEA biotechnology media, sera and reagents market size and forecast, by country

7.5.2.1. Brazil biotechnology media, sera and reagents market, by type

7.5.2.2. Brazil biotechnology media, sera and reagents market, by application

7.5.2.3. Brazil biotechnology media, sera and reagents market, by end user

7.5.2.4. Saudi Arabia biotechnology media, sera and reagents market, by type

7.5.2.5. Saudi Arabia biotechnology media, sera and reagents market, by application

7.5.2.6. Saudi Arabia biotechnology media, sera and reagents market, by end user

7.5.2.7. South Africa biotechnology media, sera and reagents market, by type

7.5.2.8. South Africa biotechnology media, sera and reagents market, by application

7.5.2.9. South Africa biotechnology media, sera and reagents market, by end user

7.5.2.10. Rest of LAMEA biotechnology media, sera and reagents market, by type

7.5.2.11. Rest of LAMEA biotechnology media, sera and reagents market, by application

7.5.2.12. Rest of LAMEA biotechnology media, sera and reagents market, by end user

7.5.3. LAMEA biotechnology media, sera and reagents market size and forecast, by type

7.5.4. LAMEA biotechnology media, sera and reagents market size and forecast, by application

7.5.5. LAMEA biotechnology media, sera and reagents market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Production capacity and facility of key companies

8.2. Becton, Dickinson and Company

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Business performance

8.2.5. Key strategic moves and developments

8.3. Bio-Rad Laboratories Inc.

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Business performance

8.4. Corning Incorporated

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Business performance

8.5. GE Healthcare

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Business performance

8.5.5. Key strategic moves and developments

8.6. HiMedia Laboratories Pvt., Ltd

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Key strategic moves and developments

8.7. Lonza Group Ltd

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Business performance

8.7.5. Key strategic moves and developments

8.8. Merck & Co., Inc.

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Key strategic moves and developments

8.9. Sartorius AG

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Business performance

8.9.5. Key strategic moves and developments

8.10. Thermo Fisher Scientific Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Business performance

8.10.5. Key strategic moves and developments


List Of Figure

LIST OF FIGURES

FIGURE 01. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018*

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018*

FIGURE 06. MARKET SHARE ANALYSIS, 2017

FIGURE 07. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 08. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY SERA MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY REAGENTS MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, 2017 AND 2025 (USD MILLION)

FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, 2017 AND 2025 (USD MILLION)

FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, 2017 AND 2025 (USD MILLION)

FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 (USD MILLION)

FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, 2017 AND 2025 (USD MILLION)

FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, 2017 AND 2025 (USD MILLION)

FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, 2017 AND 2025 (USD MILLION)

FIGURE 17. BD: NET SALES, 20152017 (USD MILLION)

FIGURE 18. BD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 19. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 20. BIO-RAD: NET SALES, 20152017 (USD MILLION)

FIGURE 21. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 22. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 23. CORNING: NET SALES, 20152017 (USD MILLION)

FIGURE 24. CORNING: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 25. CORNING: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 26. GE HEALTHCARE: NET SALES, 20152017 (USD MILLION)

FIGURE 27. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 28. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 29. LONZA: NET SALES, 20152017 (USD MILLION)

FIGURE 30. LONZA: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 31. MERCK: NET SALES, 20152016 (USD MILLION)

FIGURE 32. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 33. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 34. SARTORIUS: NET SALES, 20152017 (USD MILLION)

FIGURE 35. SARTORIUS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. SARTORIUS: REVENUE SHARE BY GEOGRAPHY, 2017(%)

FIGURE 37. THERMO FISHER: NET SALES, 20152017 (USD MILLION)

FIGURE 38. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)


List Of Table

LIST OF TABLES

TABLE 01. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKETBY TYPE, 20172025 (USD MILLION)

TABLE 02. BIOTECHNOLOGY MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 01. LYSOGENY BROTH CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 02. CHEMICALLY DEFINED CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 03. CLASSICAL CULTURE MEDIA MARKET, BY REGION, 2017 2025 (USD MILLION)

TABLE 04. SERUM-FREE CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 05. SPECIALTY CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 06. STEM CELL CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 07. OTHER CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 08. BIOTECHNOLOGY SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 09. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 10. BIOTECHNOLOGY NEW BORN CALF SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 11. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 12. BIOTECHNOLOGY REAGENTS MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 13. BIOTECHNOLOGY REAGENTS MARKET, FOR ANTIBIOTICS BY REGION, 20172025 (USD MILLION)

TABLE 14. BIOTECHNOLOGY REAGENTS MARKET, FOR DNA/RNA ISOLATION REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 15. BIOTECHNOLOGY REAGENTS MARKET, FOR PCR REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 16. BIOTECHNOLOGY REAGENTS MARKET, FOR BUFFERS BY REGION, 20172025 (USD MILLION)

TABLE 17. BIOTECHNOLOGY REAGENTS MARKET, FOR OTHER REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 18. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY APPLICATION, 20172025 (USD MILLION)

TABLE 19. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, BY REGION, 20172025 (USD MILLION)

TABLE 20. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, BY REGION, 20172025 (USD MILLION)

TABLE 21. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, BY REGION, 20172025 (USD MILLION)

TABLE 22. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 20162023 (USD MILLION)

TABLE 23. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY END USER, 20172025(USD MILLION)

TABLE 24. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, BY REGION, 20172025 (USD MILLION)

TABLE 25. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, BY REGION, 20172025(USD MILLION)

TABLE 26. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, BY REGION, 20172025(USD MILLION)

TABLE 27. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY REGION, 20172025(USD MILLION)

TABLE 28. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 29. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 30. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 31. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 32. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 33. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 34. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 35. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 36. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 37. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 38. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 39. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 40. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 41. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 42. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 43. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 44. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 45. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 46. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 47. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 48. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 49. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 50. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 51. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 52. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 53. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 54. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 55. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 56. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 57. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 58. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 59. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 60. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 61. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 62. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 63. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 64. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 65. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 66. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 67. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 68. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 69. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 70. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 71. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 72. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 73. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 74. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 75. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 76. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 77. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 78. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 79. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 80. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 81. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 82. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 83. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 84. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 85. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 86. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 87. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 88. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 89. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 90. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 91. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 92. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 93. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 94. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 95. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 96. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 97. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 98. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 99. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 100. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 101. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 102. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 103. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 104. PRODUCTION CAPACITY AND FACILITY OF KEY PLAYERS: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, 2018

TABLE 105. BD: COMPANY SNAPSHOT

TABLE 106. BD: OPERATING SEGMENTS

TABLE 107. BIO-RAD: COMPANY SNAPSHOT

TABLE 108. BIO-RAD: OPERATING SEGMENTS

TABLE 109. CORNING: COMPANY SNAPSHOT

TABLE 110. CORNING: OPERATING SEGMENTS

TABLE 111. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 112. GE HEALTHCARE: OPERATING SEGMENTS

TABLE 113. HIMEDIA: COMPANY SNAPSHOT

TABLE 114. HIMEDIA: OPERATING SEGMENTS

TABLE 115. LONZA: COMPANY SNAPSHOT

TABLE 116. LONZA: OPERATING SEGMENTS

TABLE 117. MERCK: COMPANY SNAPSHOT

TABLE 118. MERCK: OPERATING SEGMENTS

TABLE 119. MERK: PRODUCT PORTFOLIO

TABLE 120. SARTORIUS: COMPANY SNAPSHOT

TABLE 121. SARTORIUS: OPERATING SEGMENTS

TABLE 122. THERMO FISHER: COMPANY SNAPSHOT

TABLE 123. THERMO FISHER: OPERATING SEGMENTS

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

According to a new report published by Allied Market Research, titled,"Biotechnology Media, Sera and Reagent Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025,"The global biotechnology media, sera and reagents market was valued at USD 18,794 million in 2017 and is projected to reach USD 32,974 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025. North America was the highest revenue contributor in 2017 and would remain the same throughout the forecast period.

Biotechnology is the branch of science that deals with the study of living organisms and their use to make technological innovations. Media is a nutrient growth substance provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment such as lysogeny broth, serum free media, classical media, chemically defined media among others. In addition, sera are used as additional growth supplement factors owing to the presence of hormones necessary for cell growth, proliferation, and differentiation of cells. Further, reagent is a substance that is used to cause a chemical reaction. Reagents are often used to indicate the presence of another substance.

Based on biotechnology media, sera and reagents market trends by type, the reagent segment accounted for the majority of market share of the global market in 2017. This is attributed to the fact that reagents find their wide applications in all most biotechnological research such as cell culture, biopharmaceutical research and others.

Based on end user, the biotechnology and pharmaceutical company generated the maximum revenue of in 2017. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research.

Key Findings of the Biotechnology Media, Seraand Reagent Market:

Based on end user, research laboratories accounted for nearly one-third share of the biotechnology media, sera and reagents industry in 2017.

The biopharmaceuticals application segment is anticipated to grow with the highest CAGR throughout the forecast period.

Based on region, North America accounted for nearly two-fifth of the global biotechnology media, sera and reagents market share in 2017.

Asia-Pacific is anticipated to grow at the highest rate in the biotechnology media, sera and reagents market during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers, surge in R&D expenditure for the development of biotechnology media, seraand reagent, and growth in prevalence of food allergies. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase awareness & availability about different reagents & media in the market, increase in biotech R&D, and growth in presence of key market players in this region.

The report provides an extensive competitive analysis and profiles of the key market players, such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) are Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.

READ MORE

Scope

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Market share analysis, 2017

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in R&D Investment

3.4.1.2. Increase in advancements associated with cell culture media

3.4.1.3. High demand for media, sera and reagents

3.4.2. Restraints

3.4.2.1. Dearth of skilled professionals

3.4.2.2. Ethical & scientific concerns associated with culture media

3.4.3. Opportunity

3.4.3.1. Untapped potential of the emerging economies

CHAPTER 4: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Media

4.2.1. Key market trends and opportunity

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.2.4. Lysogeny broth

4.2.4.1. Market size and forecast

4.2.5. Chemically defined media

4.2.5.1. Market size and forecast

4.2.6. Classical media

4.2.6.1. Market size and forecast

4.2.7. Serum-free Media

4.2.7.1. Market size and forecast

4.2.8. Specialty media

4.2.8.1. Market size and forecast

4.2.9. Stem cell media

4.2.9.1. Market size and forecast

4.2.10. Other media

4.2.10.1. Market size and forecast

4.3. Sera

4.3.1. Key market trends and opportunity

4.3.1.1. Market size and forecast

4.3.3. Market analysis, by country

4.3.4. Fetal Bovine Sera Market

4.3.4.1. Market size and forecast

4.3.5. New Born Calf Sera

4.3.5.1. Market size and forecast

4.3.6. others

4.3.6.1. Market size and forecast

4.4. Reagent

4.4.1. Key market trends and opportunity

4.4.1.1. Market size and forecast

4.4.2. Market analysis, by country

4.4.3. Antibiotics

4.4.3.1. Market size and forecast

4.4.4. DNA/RNA Isolation Reagents

4.4.4.1. Market size and forecast

4.4.5. PCR Reagents

4.4.5.1. Market size and forecast

4.4.6. Buffers

4.4.6.1. Market size and forecast

4.4.7. Other reagents

4.4.7.1. Market size and forecast

CHAPTER 5: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Cancer research

5.2.1. Market size and forecast, by region

5.2.2. Market analysis, by country

5.3. Biopharmaceuticals

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Regenerative medicine & tissue engineering

5.4.1. Market size and forecast, by region

5.4.2. Market analysis, by country

5.5. Other Applications

5.5.1. Market size and forecast, by region

5.5.2. Market analysis, by country

CHAPTER 6: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Biotechnology & pharmaceutical industry

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Academic institute

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by country

6.4. Research laboratory

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by country

CHAPTER 7: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities

7.2.2. North America biotechnology media, sera and reagents market size and forecast, by country

7.2.2.1. U.S. market size and forecast, by type

7.2.2.2. U.S. market size and forecast, by application

7.2.2.3. U.S. biotechnology media, sera and reagents market, by end user

7.2.2.4. Canada market size and forecast, by type

7.2.2.5. Canada biotechnology media, sera and reagents market, by application

7.2.2.6. Canada biotechnology media, sera and reagents market, by end user

7.2.2.7. Mexico biotechnology media, sera and reagents market, by type

7.2.2.8. Mexico biotechnology media, sera and reagents market, by application

7.2.2.9. Mexico biotechnology media, sera and reagents market, by end user

7.2.3. North America biotechnology media, sera and reagents market size and forecast, by type

7.2.4. North America biotechnology media, sera and reagents market size and forecast, by application

7.2.5. North America biotechnology media, sera and reagents market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends

7.3.2. Europe biotechnology media, sera and reagents market size and forecast, by country

7.3.2.1. Germany market size and forecast, by type

7.3.2.2. Germany biotechnology media, sera and reagents market, by application

7.3.2.3. Germany biotechnology media, sera and reagents market, by end user

7.3.2.4. France market size and forecast, by type

7.3.2.5. France biotechnology media, sera and reagents market, by application

7.3.2.6. France biotechnology media, sera and reagents market, by end user

7.3.2.7. UK market size and forecast, by type

7.3.2.8. UK biotechnology media, sera and reagents market, by application

7.3.2.9. UK biotechnology media, sera and reagents market, by end user

7.3.2.10. Italy market size and forecast, by type

7.3.2.11. Italy biotechnology media, sera and reagents market, by application

7.3.2.12. Italy biotechnology media, sera and reagents market, by end user

7.3.2.13. Spain biotechnology media, sera and reagents market, by type

7.3.2.14. Spain biotechnology media, sera and reagents market, by application

7.3.2.15. Spain biotechnology media, sera and reagents market, by end user

7.3.2.16. Rest of Europe biotechnology media, sera and reagents market, by type

7.3.2.17. Rest of Europe biotechnology media, sera and reagents market, by application

7.3.2.18. Rest of Europe biotechnology media, sera and reagents market, by end user

7.3.3. Europe biotechnology media, sera and reagents market size and forecast, by type

7.3.4. Europe biotechnology media, sera and reagents market size and forecast, by application

7.3.5. Europe biotechnology media, sera and reagents market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends

7.4.2. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by country

7.4.2.1. Japan biotechnology media, sera and reagents market, by type

7.4.2.2. Japan biotechnology media, sera and reagents market, by application

7.4.2.3. Japan biotechnology media, sera and reagents market, by end user

7.4.2.4. China biotechnology media, sera and reagents market, by type

7.4.2.5. China biotechnology media, sera and reagents market, by application

7.4.2.6. China biotechnology media, sera and reagents market, by end user

7.4.2.7. India biotechnology media, sera and reagents market, by type

7.4.2.8. India biotechnology media, sera and reagents market, by application

7.4.2.9. India biotechnology media, sera and reagents market, by end user

7.4.2.10. Australia biotechnology media, sera and reagents market, by type

7.4.2.11. Australia biotechnology media, sera and reagents market, by application

7.4.2.12. Australia biotechnology media, sera and reagents market, by end user

7.4.2.13. South Korea biotechnology media, sera and reagents market, by type

7.4.2.14. South Korea biotechnology media, sera and reagents market, by application

7.4.2.15. South Korea biotechnology media, sera and reagents market, by end user

7.4.2.16. Taiwan biotechnology media, sera and reagents market, by type

7.4.2.17. Taiwan biotechnology media, sera and reagents market, by application

7.4.2.18. Taiwan biotechnology media, sera and reagents market, by end user

7.4.2.19. Rest of Asia-Pacific biotechnology media, sera and reagents market, by type

7.4.2.20. Rest of Asia-Pacific biotechnology media, sera and reagents market, by application

7.4.2.21. Rest of Asia-Pacific biotechnology media, sera and reagents market, by end user

7.4.3. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by type

7.4.4. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by application

7.4.5. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends

7.5.2. LAMEA biotechnology media, sera and reagents market size and forecast, by country

7.5.2.1. Brazil biotechnology media, sera and reagents market, by type

7.5.2.2. Brazil biotechnology media, sera and reagents market, by application

7.5.2.3. Brazil biotechnology media, sera and reagents market, by end user

7.5.2.4. Saudi Arabia biotechnology media, sera and reagents market, by type

7.5.2.5. Saudi Arabia biotechnology media, sera and reagents market, by application

7.5.2.6. Saudi Arabia biotechnology media, sera and reagents market, by end user

7.5.2.7. South Africa biotechnology media, sera and reagents market, by type

7.5.2.8. South Africa biotechnology media, sera and reagents market, by application

7.5.2.9. South Africa biotechnology media, sera and reagents market, by end user

7.5.2.10. Rest of LAMEA biotechnology media, sera and reagents market, by type

7.5.2.11. Rest of LAMEA biotechnology media, sera and reagents market, by application

7.5.2.12. Rest of LAMEA biotechnology media, sera and reagents market, by end user

7.5.3. LAMEA biotechnology media, sera and reagents market size and forecast, by type

7.5.4. LAMEA biotechnology media, sera and reagents market size and forecast, by application

7.5.5. LAMEA biotechnology media, sera and reagents market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Production capacity and facility of key companies

8.2. Becton, Dickinson and Company

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Business performance

8.2.5. Key strategic moves and developments

8.3. Bio-Rad Laboratories Inc.

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Business performance

8.4. Corning Incorporated

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Business performance

8.5. GE Healthcare

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Business performance

8.5.5. Key strategic moves and developments

8.6. HiMedia Laboratories Pvt., Ltd

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Key strategic moves and developments

8.7. Lonza Group Ltd

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Business performance

8.7.5. Key strategic moves and developments

8.8. Merck & Co., Inc.

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product portfolio

8.8.5. Key strategic moves and developments

8.9. Sartorius AG

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Business performance

8.9.5. Key strategic moves and developments

8.10. Thermo Fisher Scientific Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Business performance

8.10.5. Key strategic moves and developments


List Of Figure

LIST OF FIGURES

FIGURE 01. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018*

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018*

FIGURE 06. MARKET SHARE ANALYSIS, 2017

FIGURE 07. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 08. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY SERA MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY REAGENTS MARKET, 2017 AND 2025 (USD MILLION)

FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, 2017 AND 2025 (USD MILLION)

FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, 2017 AND 2025 (USD MILLION)

FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, 2017 AND 2025 (USD MILLION)

FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 (USD MILLION)

FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, 2017 AND 2025 (USD MILLION)

FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, 2017 AND 2025 (USD MILLION)

FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, 2017 AND 2025 (USD MILLION)

FIGURE 17. BD: NET SALES, 20152017 (USD MILLION)

FIGURE 18. BD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 19. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 20. BIO-RAD: NET SALES, 20152017 (USD MILLION)

FIGURE 21. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 22. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 23. CORNING: NET SALES, 20152017 (USD MILLION)

FIGURE 24. CORNING: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 25. CORNING: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 26. GE HEALTHCARE: NET SALES, 20152017 (USD MILLION)

FIGURE 27. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 28. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 29. LONZA: NET SALES, 20152017 (USD MILLION)

FIGURE 30. LONZA: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 31. MERCK: NET SALES, 20152016 (USD MILLION)

FIGURE 32. MERCK: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 33. MERCK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

FIGURE 34. SARTORIUS: NET SALES, 20152017 (USD MILLION)

FIGURE 35. SARTORIUS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. SARTORIUS: REVENUE SHARE BY GEOGRAPHY, 2017(%)

FIGURE 37. THERMO FISHER: NET SALES, 20152017 (USD MILLION)

FIGURE 38. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)


List Of Table

LIST OF TABLES

TABLE 01. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKETBY TYPE, 20172025 (USD MILLION)

TABLE 02. BIOTECHNOLOGY MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 01. LYSOGENY BROTH CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 02. CHEMICALLY DEFINED CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 03. CLASSICAL CULTURE MEDIA MARKET, BY REGION, 2017 2025 (USD MILLION)

TABLE 04. SERUM-FREE CULTURE MEDIA MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 05. SPECIALTY CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 06. STEM CELL CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 07. OTHER CULTURE MEDIA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 08. BIOTECHNOLOGY SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 09. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 10. BIOTECHNOLOGY NEW BORN CALF SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 11. BIOTECHNOLOGY FETAL BOVINE SERA MARKET, BY REGION, 20172025 (USD MILLION)

TABLE 12. BIOTECHNOLOGY REAGENTS MARKET, BY REGION, 2017-2025 (USD MILLION)

TABLE 13. BIOTECHNOLOGY REAGENTS MARKET, FOR ANTIBIOTICS BY REGION, 20172025 (USD MILLION)

TABLE 14. BIOTECHNOLOGY REAGENTS MARKET, FOR DNA/RNA ISOLATION REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 15. BIOTECHNOLOGY REAGENTS MARKET, FOR PCR REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 16. BIOTECHNOLOGY REAGENTS MARKET, FOR BUFFERS BY REGION, 20172025 (USD MILLION)

TABLE 17. BIOTECHNOLOGY REAGENTS MARKET, FOR OTHER REAGENTS BY REGION, 20172025 (USD MILLION)

TABLE 18. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY APPLICATION, 20172025 (USD MILLION)

TABLE 19. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR CANCER RESEARCH, BY REGION, 20172025 (USD MILLION)

TABLE 20. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOPHARMACEUTICALS, BY REGION, 20172025 (USD MILLION)

TABLE 21. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING, BY REGION, 20172025 (USD MILLION)

TABLE 22. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 20162023 (USD MILLION)

TABLE 23. GLOBAL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY END USER, 20172025(USD MILLION)

TABLE 24. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRY, BY REGION, 20172025 (USD MILLION)

TABLE 25. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR ACADEMIC INSTITUTE, BY REGION, 20172025(USD MILLION)

TABLE 26. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET FOR RESEARCH LABORATORY, BY REGION, 20172025(USD MILLION)

TABLE 27. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET REVENUE, BY REGION, 20172025(USD MILLION)

TABLE 28. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 29. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 30. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 31. U.S. BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 32. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 33. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 34. CANADA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 35. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 36. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 37. MEXICO BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 38. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 39. NORTH AMERICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 40. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 41. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 42. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 43. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 44. GERMANY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 45. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 46. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 47. FRANCE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 48. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 49. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 50. UK BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 51. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 52. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 53. ITALY BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 54. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 55. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 56. SPAIN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 57. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 58. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 59. REST OF EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 60. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 61. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 62. EUROPE BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 63. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 64. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 65. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 66. JAPAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 67. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 68. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 69. CHINA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 70. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 71. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 72. INDIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 73. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 74. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 75. AUSTRALIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 76. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 77. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 78. SOUTH KOREA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 79. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 80. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 81. TAIWAN BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 82. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 83. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 84. REST OF ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 85. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 86. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 87. ASIA-PACIFIC BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 88. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY COUNTRY, 20172025(USD MILLION)

TABLE 89. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 90. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 91. BRAZIL BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 92. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 93. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 94. SAUDI ARABIA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 95. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 96. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 97. SOUTH AFRICA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 98. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 99. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 100. REST OF LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 101. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE, 20172025(USD MILLION)

TABLE 102. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY APPLICATION, 20172025(USD MILLION)

TABLE 103. LAMEA BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER, 20172025(USD MILLION)

TABLE 104. PRODUCTION CAPACITY AND FACILITY OF KEY PLAYERS: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, 2018

TABLE 105. BD: COMPANY SNAPSHOT

TABLE 106. BD: OPERATING SEGMENTS

TABLE 107. BIO-RAD: COMPANY SNAPSHOT

TABLE 108. BIO-RAD: OPERATING SEGMENTS

TABLE 109. CORNING: COMPANY SNAPSHOT

TABLE 110. CORNING: OPERATING SEGMENTS

TABLE 111. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 112. GE HEALTHCARE: OPERATING SEGMENTS

TABLE 113. HIMEDIA: COMPANY SNAPSHOT

TABLE 114. HIMEDIA: OPERATING SEGMENTS

TABLE 115. LONZA: COMPANY SNAPSHOT

TABLE 116. LONZA: OPERATING SEGMENTS

TABLE 117. MERCK: COMPANY SNAPSHOT

TABLE 118. MERCK: OPERATING SEGMENTS

TABLE 119. MERK: PRODUCT PORTFOLIO

TABLE 120. SARTORIUS: COMPANY SNAPSHOT

TABLE 121. SARTORIUS: OPERATING SEGMENTS

TABLE 122. THERMO FISHER: COMPANY SNAPSHOT

TABLE 123. THERMO FISHER: OPERATING SEGMENTS

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS